The main liability of P2X7 in AT inflammation and obesity was at first suggested by the fact that visceral and subcutaneous AT expresses functional P2X7 receptors (both mRNA and protein) and by the notion that such expression is higher in subjects with metabolic syndrome (57). Here, P2RX7 is linked to obesity disorder.